Literature DB >> 15296047

Integrating the child into home and community following the completion of cancer treatment.

Larissa E Labay1, Sherri Mayans, Michael B Harris.   

Abstract

The present article examines the period of time immediately following the completion of treatment for childhood cancer. The unique concerns experienced by families at this stage of the cancer treatment are examined, and the specific challenges that children face as they renegotiate roles and relationships that are necessary for successful reintegration into family, school, and community settings are discussed. Obstacles to successful reintegration that are frequently encountered by patients and families are reviewed, as well as variables that may promote optimal adjustment during this transitional period. The need for continued research in this area is highlighted, and specific research questions are identified. An emphasis is placed on applying a socioecological framework to research and clinical work with pediatric oncology patients at this stage of the cancer experience.

Entities:  

Mesh:

Year:  2004        PMID: 15296047     DOI: 10.1177/1043454204264396

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  3 in total

1.  The role of rehabilitation measures in reintegration of children with brain tumours or leukaemia and their families after completion of cancer treatment: a study protocol.

Authors:  Mona Leandra Peikert; Laura Inhestern; Corinna Bergelt
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

Review 2.  Psychosocial interventions for rehabilitation and reintegration into daily life of pediatric cancer survivors and their families: A systematic review.

Authors:  Mona Leandra Peikert; Laura Inhestern; Corinna Bergelt
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

3.  Returning to daily life: a qualitative interview study on parents of childhood cancer survivors in Germany.

Authors:  Mona L Peikert; Laura Inhestern; Konstantin A Krauth; Gabriele Escherich; Stefan Rutkowski; Daniela Kandels; Corinna Bergelt
Journal:  BMJ Open       Date:  2020-03-08       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.